Literature DB >> 22678926

Synthesis and catalytic properties of hybrid mesoporous materials assembled from polyhedral and bridged silsesquioxane monomers.

Urbano Díaz1, Teresa García, Alexandra Velty, Avelino Corma.   

Abstract

A family of hybrid mesoporous materials with high temperature stability was obtained by the suitable covalent combination of two types of siloxane precursors. Specifically, cubic T(8) polyhedral oligomeric (POSS) and aryl bridged silsesquioxane monomers (1,4-bis(triethoxysilyl)benzene, BTEB) play the role of nanobuilders. An optimal molar ratio of the two precursors (5-25 mol% of total silicon content from the BTEB disilane) generated a homogenous, highly accessible, and well-defined mesoporous material with hexagonal symmetry and narrow pore-size distribution. Physicochemical, textural, and spectroscopic analysis corroborated the effective integration and preservation of the two different nanoprecursors, thereby confirming the framework of the mesoporous hybrid materials. A post-synthesis amination treatment allowed the effective incorporation of amino groups onto the aryl linkers, thereby obtaining a stable and recyclable basic catalyst for use in C-C bond-formation processes.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2012        PMID: 22678926     DOI: 10.1002/chem.201200170

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  Construction of porous cationic frameworks by crosslinking polyhedral oligomeric silsesquioxane units with N-heterocyclic linkers.

Authors:  Guojian Chen; Yu Zhou; Xiaochen Wang; Jing Li; Shuang Xue; Yangqing Liu; Qian Wang; Jun Wang
Journal:  Sci Rep       Date:  2015-06-11       Impact factor: 4.379

2.  Rare Earth Doped Silica Nanoparticles via Thermolysis of a Single Source Metallasilsesquioxane Precursor.

Authors:  Gemma-Louise Davies; John O'Brien; Yurii K Gun'ko
Journal:  Sci Rep       Date:  2017-04-05       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.